FindTrial
Sign In

Effect of haemodialysis on blood lipid levels.

New Look at Lipid Abnormalities in Hemodialysis Patients - NLLAHP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023470
Enrollment
120
Registered
2020-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Shanthi Naidu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Randomly selected adult patients with ESRD on maintenance haemodialysis. 2. who is ready to give consent to study and sample collection are selected.

Exclusion criteria

Exclusion criteria: 1. Patients with acute kidney injury 2. Patients with chronic liver disease 3. Patients on peritoneal dialysis

Design outcomes

Primary

MeasureTime frame
1.To demonstrate lipid levels in blood rise after hemodialysis. 2.lipid components are filtered across the dialysis membrane. Timepoint: 4 hours after initiation of haemodialysis.—

Secondary

MeasureTime frame
1.Determinants of post dialysis rise determined by multiple factore including ultrafiltration. 2.Fasting lipid levels are not actual lipids for hemodialysis patients.Timepoint: 4 hours after initiation of haemodialysis session.—

Countries

India

Contacts

Public ContactDr Girish Vasudev Kumthekar

Renown Clinical Services and Star Hospitals

drgirishkumthekar@gmail.com7032295272

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026